The real question is still the quantities of antibody types the mRNA layer will produce. If it behaves as it has in tests, the ratio of binding to neutralizing antibodies will put people with the vaccine at serious risk of exposure to mutant strains of the virus.
The real question is still the quantities of antibody types the mRNA layer will produce. If it behaves as it has in tests, the ratio of binding to neutralizing antibodies will put people with the vaccine at serious risk of exposure to mutant strains of the virus.
(post is archived)